News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
Market overviews
Direct comparison of products for laboratory and process: Use the comprehensive market overviews to compare products according to your requirements and obtain further information from suppliers.
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
01-Dec-2010 - AiCuris GmbH & Co. KG has been awarded a three-year research grant together with the Universities of Bochum, Düsseldorf and Bonn as well as the company Squarix (Marl). This grant is a part of the research promotion program “Bio.NRW” by the Ministry of Innovation, Science and Research of North ...
09-Nov-2010 - AiCuris announced the presentation of preclinical and Phase 1 data on AIC316 at the Antivirals Congress in Amsterdam, Netherlands. AIC316 is a novel anti-HSV drug currently in clinical phase 2 testing. AiCuris scientist and project leader Dr. Alexander Birkmann will give an overview on the ...
22-Oct-2010 - AiCuris announced that its novel HCMV inhibitor AIC246 has been used successfully to treat a patient with multi-organ HCMV disease caused by multi-resistant virus. Details will be presented at the 48th IDSA meeting on October 23. “This is the first case, where HCMV disease has been treated and ...
05-Jul-2010 - AiCuris announced that its resistance-breaking NNRTI (Non-Nucleosidic Reverse Transcriptase Inhibitor) for HIV has entered human phase I clinical trials. Following oral administration the compound was generally well tolerated and the resulting pharmacokinetic profile was indicative of the ...
11-May-2010 - AiCuris announced that its novel HCMV inhibitor AIC246 is now being tested in a phase IIb trial with bone marrow transplant recipients. First patients have already been included into the trial. AIC246 is under development for the treatment of HCMV (humane cytomegalovirus) infections in transplant ...
10-Nov-2009 - AiCuris announced that three phase I studies with its novel compound AIC316 for the treatment of herpes simplex virus infections have been completed successfully. AIC316 is a first-in-class helicase-primase inhibitor. More than 120 volunteers were exposed in single-dose, multiple-dose and food ...
16-Sep-2009 - AiCuris presented first phase II data for its novel non-nucleosidic HCMV inhibitor at the 49th ICAAC meeting in San Francisco demonstrating a good tolerability of AIC246 in transplant recipients and an efficacy comparable to standard of care. In this phase II study, a total of 27 patients (26 ...
© 1997-2024 LUMITOS AG, All rights reserved